Publication | Closed Access

Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers

Gene TherapiesCrispr/cas9 PlasmidEngineeringGenetic EngineeringDonor OligonucleotideGenome EngineeringGenome EditingBiomedical EngineeringGene EditingGene DeliveryGene VectorMedicineCrisprBiomolecular Engineering